In the latest close session, Recursion Pharmaceuticals (RXRX) was down 1.87% at $2.89. This change lagged the S&P 500's daily loss of 0.19%. At the same time, the Dow lost 0.59%, and the tech-heavy ...

How has testosterone been historically misunderstood, and what implications does that have for current public policy?

More than a hundred protestors marched between the San Francisco headquarters of Anthropic PBC and OpenAI earlier this month, ...

Wood’s ARK Invest’s largest purchase by value during July 13-17 was Elon Musk’s Space Exploration Technologies (SPCX), with ...

Wharton economist Mohamed El-Erian sees the inflation battle as largely won, but he is already timing out a specific window ...

Tempus AI Inc. TEM investors have a decision to make. Shares of the precision medicine company fell nearly 6% Monday, taking ...

Writer's new AI harness study cuts enterprise token spend by 38% and cost per task by 41% across six foundation models, ...

In “Dog Days,” LaBarge blurs the lines between memoir and criticism. Over the course of a career, what a critic trains her ...

Infinity.inc (Infinity Artificial Intelligence Institute), an early-stage AI infrastructure research company building the software layer that makes any AI chip inference-ready, today announced it has ...

As tensions rise between China and Taiwan, Bloomberg Economics estimates the potential cost of a conflict at $10 trillion, ...

By the end of 2027, when Sim Tshabalala steps down as CEO of Standard Bank Group, five of South Africa’s six largest banks ...